UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Clinical infectious diseases, 2007-09, Vol.45 (6), p.753-760

2007

Volltextzugriff (PDF)

Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults

Antimicrobial Agents and Chemotherapy, 2006-04, Vol.50 (4), p.1222-1227

2006

Volltextzugriff (PDF)

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.623-629

1999

Volltextzugriff (PDF)

The Absolute Bioavailability of Oral Melatonin

Journal of clinical pharmacology, 2000-07, Vol.40 (7), p.781-784

2000

Volltextzugriff (PDF)

Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing

Antimicrobial Agents and Chemotherapy, 1997-05, Vol.41 (5), p.1115-1119

1997

Volltextzugriff (PDF)

Aminoglycoside dosing weight correction factors for patients of various body sizes

Antimicrobial Agents and Chemotherapy, 1995-02, Vol.39 (2), p.545-548

1995

Volltextzugriff (PDF)

Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1842-1844

1998

Volltextzugriff (PDF)

Low Hepatic Cytochrome P450 3A Activity is a Risk for Corticosteroid-induced Osteonecrosis

Clinical pharmacology and therapeutics, 2007-10, Vol.82 (4), p.379-379

2007

Volltextzugriff (PDF)

Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions

Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2466-2470

1997

Volltextzugriff (PDF)

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam

Clinical pharmacology and therapeutics, 1998-09, Vol.64 (3), p.269-277

1998

Volltextzugriff (PDF)

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

The Journal of infectious diseases, 1993-01, Vol.167 (1), p.173-179

1993

Volltextzugriff (PDF)

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N‐acetyltransferase‐2, and xanthine oxidase with the “Cooperstown cocktail”

Clinical pharmacology and therapeutics, 2000-10, Vol.68 (4), p.375-383

2000

Volltextzugriff (PDF)

Prediction of Response to Hepatitis B Vaccine in Health Care Workers: Whose Titers of Antibody to Hepatitis B Surface Antigen Should Be Determined After a Three-Dose Series, and What Are the Implications in Terms of Cost-Effectiveness?

Clinical infectious diseases, 1998-03, Vol.26 (3), p.566-571

1998

Volltextzugriff (PDF)

Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping

Clinical pharmacology and therapeutics, 1998-05, Vol.63 (5), p.540-551

1998

Volltextzugriff (PDF)

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping

Clinical pharmacology and therapeutics, 1998-09, Vol.64 (3), p.257-268

1998

Volltextzugriff (PDF)

Effects of Oral Vitamin K on S- and R-Warfarin Pharmacokinetics and Pharmacodynamics: Enhanced Safety of Warfarin as a CYP2C9 Probe

Journal of clinical pharmacology, 2001-07, Vol.41 (7), p.715-722

2001

Volltextzugriff (PDF)

Methicillin-resistant Staphylococcus aureus outbreak: A consensus panel's definition and management guidelines

American journal of infection control, 1998-04, Vol.26 (2), p.102-110

1998

Volltextzugriff (PDF)

Effect of intravenous flumazenil on oral midazolam pharmacokinetics and pharmacodynamics for use as a cytochrome P450 3A probe

International journal of clinical pharmacology and therapeutics, 2009-02, Vol.47 (2), p.111-119

2009

Volltextzugriff (PDF)

A Comparative Trial of Standard or High-Dose S Subunit Recombinant Hepatitis B Vaccine versus a Vaccine Containing S Subunit, Pre-S1, and Pre-S2 Particles for Revaccination of Healthy Adult Nonresponders

The Journal of infectious diseases, 1997-03, Vol.175 (3), p.678-681

1997

Volltextzugriff (PDF)

Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus

American journal of health-system pharmacy, 1997-10, Vol.54 (19), p.2185-2191

BERTINO, J. S

1997

Volltextzugriff (PDF)

A Dose-Ranging Study of Gentamicin Pharmacokinetics: Implications for Extended Interval Aminoglycoside Therapy

Journal of clinical pharmacology, 2001-04, Vol.41 (4), p.374-377

2001

Volltextzugriff (PDF)

Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy

The journal of clinical psychiatry, 1999-03, Vol.60 (3), p.187-190

1999

Volltextzugriff (PDF)

Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors

Clinical infectious diseases, 2002-03, Vol.34 (6), p.861-863

2002

Volltextzugriff (PDF)

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

The American Journal of Medicine, 2002-12, Vol.113 (9), p.746-750

2002

Volltextzugriff (PDF)

Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping

Clinical pharmacology and therapeutics, 1999-11, Vol.66 (5), p.535-541

1999

Volltextzugriff (PDF)

1 – 25 von 1.632

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.178)
Mit Volltextzugriff
(1.224)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.166)
Humans
(640)
Life Sciences & Biomedicine
(636)
Technology
(447)
Computer Science
(419)
Biological And Medical Sciences
(269)
Computer Science, Theory & Methods
(263)
Computer Science, Information Systems
(262)
Female
(259)
Medical Sciences
(230)
Male
(215)
Oncology
(211)
Animals
(202)
Pharmacology. Drug Treatments
(178)
Adult
(176)
Software
(146)
Engineering
(145)
Engineering, Electrical & Electronic
(142)
Pharmacology & Pharmacy
(135)
Exact Sciences And Technology
(130)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(764)
Ingenta
(552)
EZB Free E-Journals
(504)
Journals@Ovid Complete
(476)
Single Journals
(401)
IEEE Electronic Library (IEL)
(281)
Wiley Online Library Journals Frontfile Complete
(233)
Elsevier ScienceDirect Journals Complete
(208)
SpringerLink Series
(183)
Elsevier ScienceDirect Journals Complete
(163)
Wiley Online Library Full Collection 2018
(161)
IngentaConnect Journals
(121)
Ebook Central Perpetual and DDA
(47)
Oxford journals
(45)
eBooks on EBSCOhost
(45)
JSTOR
(44)
SpringerLink Journals - AutoHoldings
(43)
Nature
(37)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(32)
Nexis Uni
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

The Absolute Bioavailability of Oral Melatonin

Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing

Aminoglycoside dosing weight correction factors for patients of various body sizes

Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

Low Hepatic Cytochrome P450 3A Activity is a Risk for Corticosteroid-induced Osteonecrosis

Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N‐acetyltransferase‐2, and xanthine oxidase with the “Cooperstown cocktail”

Prediction of Response to Hepatitis B Vaccine in Health Care Workers: Whose Titers of Antibody to Hepatitis B Surface Antigen Should Be Determined After a Three-Dose Series, and What Are the Implications in Terms of Cost-Effectiveness?

Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping

Effects of Oral Vitamin K on S- and R-Warfarin Pharmacokinetics and Pharmacodynamics: Enhanced Safety of Warfarin as a CYP2C9 Probe

Methicillin-resistant Staphylococcus aureus outbreak: A consensus panel's definition and management guidelines

Effect of intravenous flumazenil on oral midazolam pharmacokinetics and pharmacodynamics for use as a cytochrome P450 3A probe

A Comparative Trial of Standard or High-Dose S Subunit Recombinant Hepatitis B Vaccine versus a Vaccine Containing S Subunit, Pre-S1, and Pre-S2 Particles for Revaccination of Healthy Adult Nonresponders

Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus

A Dose-Ranging Study of Gentamicin Pharmacokinetics: Implications for Extended Interval Aminoglycoside Therapy

Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy

Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping

Aktive Filter

Suchergebnisse filtern